Bharat N.S.

Asia Health India

India rejects patent on Pfizer’s arthritis drug

India has again denied Pfizer Inc. a patent on its rheumatoid arthritis drug Tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the…

Read More

Page 1 of 1


Welcome! Login in to your account

Remember me Lost your password?

Lost Password